nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of endpoints used in marketing authorisations versus value assessments of oncology medicines in Germany
|
Ruof, Jörg |
|
2014 |
118 |
2 |
p. 242-254 13 p. |
artikel |
2 |
Contents
|
|
|
2014 |
118 |
2 |
p. iv-v nvt p. |
artikel |
3 |
Editorial Board
|
|
|
2014 |
118 |
2 |
p. iii- 1 p. |
artikel |
4 |
First- and fifth-year medical students’ intention for emigration and practice abroad: A case study of Serbia
|
Santric-Milicevic, Milena M. |
|
2014 |
118 |
2 |
p. 173-183 11 p. |
artikel |
5 |
Foregoing medicines in the former Soviet Union: Changes between 2001 and 2010
|
Footman, Katharine |
|
2014 |
118 |
2 |
p. 184-192 9 p. |
artikel |
6 |
Geographic disparities in the utilisation of computed tomography scanning services in southern New Zealand
|
Nixon, Garry |
|
2014 |
118 |
2 |
p. 222-228 7 p. |
artikel |
7 |
Geographic variation in rates of common surgical procedures in France in 2008–2010, and comparison to the US and Britain
|
Weeks, William B. |
|
2014 |
118 |
2 |
p. 215-221 7 p. |
artikel |
8 |
Healthcare financing reform in Latvia: Switching from social health insurance to NHS and back?
|
Mitenbergs, Uldis |
|
2014 |
118 |
2 |
p. 147-152 6 p. |
artikel |
9 |
Health policies 25 years after the fall of the Iron Curtain
|
Busse, Reinhard |
|
2014 |
118 |
2 |
p. 145-146 2 p. |
artikel |
10 |
Implementation of the 2011 Therapeutic Activity Act: Will commercialization improve the financial performance of Polish hospitals?
|
Sagan, Anna |
|
2014 |
118 |
2 |
p. 153-158 6 p. |
artikel |
11 |
In search of patient-centred care in middle income countries: The experience of diabetes care in the former Soviet Union
|
Kühlbrandt, Charlotte |
|
2014 |
118 |
2 |
p. 193-200 8 p. |
artikel |
12 |
Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States
|
Kanavos, Panos |
|
2014 |
118 |
2 |
p. 229-241 13 p. |
artikel |
13 |
Primary care principles and community health centers in the countries of former Yugoslavia
|
Klančar, Darinka |
|
2014 |
118 |
2 |
p. 166-172 7 p. |
artikel |
14 |
Re: “Early benefit assessment of new drugs in Germany – Results from 2011 to 2012” [Health Policy 116 (2–3) (2014) 147–153]
|
Orben, Tina |
|
2014 |
118 |
2 |
p. 271- 1 p. |
artikel |
15 |
Response to Letter to the Editor on “Early benefit assessment of new drugs in Germany – Results from 2011 to 2012” [Health Policy 116(2–3) (2014) 147–153]
|
Hörn, Helmut |
|
2014 |
118 |
2 |
p. 272- 1 p. |
artikel |
16 |
The paradox of public participation in the healthcare in Poland – What citizens want, and what they think
|
Kolasa, Katarzyna |
|
2014 |
118 |
2 |
p. 159-165 7 p. |
artikel |
17 |
The path of least resistance: Paying for antibiotics in non-human uses
|
Hollis, Aidan |
|
2014 |
118 |
2 |
p. 264-270 7 p. |
artikel |
18 |
Transparency in Canadian public drug advisory committees
|
Rosenberg-Yunger, Zahava R.S. |
|
2014 |
118 |
2 |
p. 255-263 9 p. |
artikel |
19 |
Understanding shortages of sufficient health care in rural areas
|
Weinhold, Ines |
|
2014 |
118 |
2 |
p. 201-214 14 p. |
artikel |